Journal title MECOSAN
Author/s Andrea Garlatti, Valentina Bruni
Publishing Year 2015 Issue 2014/91 Language Italian
Pages 24 P. 81-104 File size 639 KB
DOI is like a bar code for intellectual property: to have more infomation click here
Below, you can see the article first page
If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits
FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.
The debate on costs of pharmaceutical distribution is often affected by ideological premises (public versus private) when empirical data should be more important. The article analyses a case of pharmaceutical distribution operated by a public healthcare organization, considering activities, costs and results. The article analyses strength and weakness points of the different solutions available in the case and shows that when public healthcare organisation and private external distributors act in partnership it is possible to achieve the best results, both on the side of quality and on the side of costs. The analysis offers an example of the different factors that influence the level of costs; shows the importance of economic evaluations and points out that efficiency is not related to the nature (public or private) of the distributing subject.
Keywords: Pharmaceutical distribution, costs, public private partnership.
Andrea Garlatti, Valentina Bruni, Distribuzione dei farmaci: gestione diretta o tramite farmacie? Materiali e metodi da un caso aziendale in "MECOSAN" 91/2014, pp 81-104, DOI: 10.3280/MESA2014-091005